It was observed that serum PVT1 level is mostly increased in CC patients and correlated with tumor size, FIGO stage and lymph node metastasis, demonstrating that PVT1 may be a novel noninvasive biomarker for early diagnosis of CC [85]. This evidence concerns the gene PVT1 and metastatic malignant neoplasm in the lymph nodes.